July 9th, 2026
Hospital del Mar Research Institute is participating in this European project, which aims to advance knowledge of the functions of the proteins that make up the so-called dark proteome. Led by the Princess Máxima Center for Pediatric Oncology in the Netherlands, it will train fifteen PhD students, who will focus their research on this field.
Read more sobre "ORFeus, boosting research into the dark proteome"
June 18, 2026
A study in mice by the Hospital del Mar Research Institute and the IIBB-CSIC, published in Science Advances, identifies inhibition of the PARP2 protein as a therapeutic target for treating pancreatic cancer, the third leading cause of cancer death worldwide. The study analyses the role of this protein in tumour development and protection, and describes how its elimination leads to tumour cell death and activation of the immune System. Specifically blocking this protein may be a useful strategy for treating a large number of patients with pancreatic cancer and could even be applicable to other types of tumours.
May 19th, 2026
An international study involving researchers from the Hospital del Mar Research Institute reveals a key interaction between two proteins that are fundamental in tumour development. To achieve this, molecular modelling and artificial intelligence techniques were used, revealing for the first time a new structural model that describes a previously unknown cell-signalling mechanism. The research opens the door to designing drugs that act on the interaction between the two proteins, thereby improving current cancer treatments.
Read more sobre "A new pathway for developing cancer drugs discovered"
5-9 de octubre del 2026
7-9 de octubre del 2026
Parc Salut Mar
Passeig Marítim 25-29 Barcelona 08003
See location on Google maps
Phone: 93 248 30 00 · Fax: 93 248 32 54
Information request
© 2006 - 2026 Hospital del Mar · Legal notice and Privacy Police | Cookie Policy | Accessibility
